Human Genetic Intervention: Past, Present, and Future - Is Human Nature Obsolete? - page 384

16. Office of Biotechnology Activities, “Recombinant DNA Research: Action
under the NIH Guidelines,” Federal Register 65, no. 239 (December 12, 2000):
77655-77659; and Office of Biotechnology Activities, “Recombinant DNA
Research: Proposed Actions under the NIH Guidelines,” Federal Register 66,
no. 223 (November 19, 2001): 57970-57977.
17. Office of Biotechnology Activities, “Recombinant DNA Research: Notice
under the NIH Guidelines,” Federal Register 67, no. 101 (May 24, 2002):
36619-36620.
18. Food and Drug Administration, “Availability for Public Disclosure and Sub-
mission to FDA for Public Disclosure of Certain Data and Information Related
to Human Gene Therapy or Xenotransplantation,” Federal Register 66, no. 12
(January 18, 2001): 4688-4706.
19. See Jonathan Bor and Gary Cohn, “Research Volunteer Dies in Hopkins
Asthma Study,” Baltimore Sun , 14 July 2001, A1.
20. Food and Drug Administration, press release, October 26, 2001 (no longer
available).
21. See William M. Rideout III, Konrao Hochedlinger, Michael Kyba “Correc-
tion of a Genetic Defect by Nuclear Transplantation and Combined Cell and
Gene Therapy,” Cell 109, no. 1 (April 5, 2002): 17-27.
22. See Panayotis K. Thanos, Nora D. Volkow, Paul Freimuth, “Overexpression
of Dopamine D2 Receptors Reduces Alcohol Self-Administration,” Journal of
Neurochemistry 78, no. 5 (September 2001): 1094-1103.
23. On this topic, see LeRoy Walters and Julie Gage Palmer, The Ethics of
Human Gene Therapy (New York: Oxford University Press 1997), 99-142.
24. On the topic of germ line intervention, see Walters and Palmer, The Ethics
of Human Gene Therapy , 143-153.